Leonard E. Post's most recent trade in uniQure N.V. was a trade of 2,112 Ordinary Shares done at an average price of $14.4 . Disclosure was reported to the exchange on June 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| uniQure N.V. | Leonard E. Post | Director | Sale of securities on an exchange or to another person at price $ 14.45 per share. | 20 Jun 2025 | 2,112 | 29,937 (0%) | 0% | 14.4 | 30,518 | Ordinary Shares |
| uniQure N.V. | Leonard E. Post | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 15,630 | 15,630 | - | - | Stock Option (Right to Buy) | |
| uniQure N.V. | Leonard E. Post | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 7,970 | 32,049 (0%) | 0% | 0 | Ordinary Shares | |
| Cg Oncology Inc. | Leonard E. Post | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 24,165 | 24,165 | - | - | Director Stock Option (right to buy) | |
| Cg Oncology Inc. | Leonard E. Post | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 21 May 2025 | 1,000 | 1,000 | - | 0.6 | 600 | Common Stock |
| Cg Oncology Inc. | Leonard E. Post | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 1,000 | 128,077 | - | - | Director Stock Option (right to buy) | |
| Cg Oncology Inc. | Leonard E. Post | Director | Sale of securities on an exchange or to another person at price $ 28.00 per share. | 21 May 2025 | 1,000 | 0 | - | 28 | 28,000 | Common Stock |
| Cg Oncology Inc. | Leonard E. Post | Director | Sale of securities on an exchange or to another person at price $ 30.76 per share. | 28 Apr 2025 | 1,000 | 0 | - | 30.8 | 30,760 | Common Stock |
| Cg Oncology Inc. | Leonard E. Post | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 28 Apr 2025 | 1,000 | 1,000 | - | 0.6 | 600 | Common Stock |
| Cg Oncology Inc. | Leonard E. Post | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2025 | 1,000 | 129,077 | - | - | Director Stock Option (right to buy) | |
| Cg Oncology Inc. | Leonard E. Post | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2025 | 1,000 | 130,077 | - | - | Director Stock Option (right to buy) | |
| Cg Oncology Inc. | Leonard E. Post | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 17 Mar 2025 | 1,000 | 1,000 | - | 0.6 | 600 | Common Stock |
| Cg Oncology Inc. | Leonard E. Post | Director | Sale of securities on an exchange or to another person at price $ 28.00 per share. | 17 Mar 2025 | 1,000 | 0 | - | 28 | 28,000 | Common Stock |
| Cg Oncology Inc. | Leonard E. Post | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 18 Feb 2025 | 1,000 | 1,000 | - | 0.6 | 600 | Common Stock |
| Cg Oncology Inc. | Leonard E. Post | Director | Sale of securities on an exchange or to another person at price $ 28.61 per share. | 18 Feb 2025 | 1,000 | 0 | - | 28.6 | 28,610 | Common Stock |
| Cg Oncology Inc. | Leonard E. Post | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 1,000 | 131,077 | - | - | Director Stock Option (right to buy) | |
| Cg Oncology Inc. | Leonard E. Post | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 13 Jan 2025 | 1,000 | 1,000 | - | 0.6 | 600 | Common Stock |
| Cg Oncology Inc. | Leonard E. Post | Director | Sale of securities on an exchange or to another person at price $ 29.66 per share. | 13 Jan 2025 | 1,000 | 0 | - | 29.7 | 29,660 | Common Stock |
| Cg Oncology Inc. | Leonard E. Post | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2025 | 1,000 | 132,077 | - | - | Director Stock Option (right to buy) | |
| Cg Oncology Inc. | Leonard E. Post | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2024 | 1,000 | 133,077 | - | - | Stock Option | |
| Cg Oncology Inc. | Leonard E. Post | Director | Sale of securities on an exchange or to another person at price $ 28.84 per share. | 16 Dec 2024 | 1,000 | 0 | - | 28.8 | 28,840 | Common Stock |
| Cg Oncology Inc. | Leonard E. Post | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 16 Dec 2024 | 1,000 | 1,000 | - | 0.6 | 600 | Common Stock |
| Cg Oncology Inc. | Leonard E. Post | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 1,000 | 134,077 | - | - | Stock Option | |
| Cg Oncology Inc. | Leonard E. Post | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 06 Dec 2024 | 1,000 | 1,000 | - | 0.6 | 600 | Common Stock |
| Cg Oncology Inc. | Leonard E. Post | Director | Sale of securities on an exchange or to another person at price $ 34.40 per share. | 06 Dec 2024 | 750 | 250 | - | 34.4 | 25,798 | Common Stock |
| Cg Oncology Inc. | Leonard E. Post | Director | Sale of securities on an exchange or to another person at price $ 34.98 per share. | 06 Dec 2024 | 250 | 0 | - | 35.0 | 8,744 | Common Stock |
| Cg Oncology Inc. | Leonard E. Post | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 15,600 | 15,600 | - | - | Stock Option (Right to Buy) | |
| uniQure N.V. | Leonard E. Post | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2024 | 15,840 | 15,840 | - | - | Stock Option (Right to Buy) | |
| uniQure N.V. | Leonard E. Post | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2024 | 8,080 | 24,079 (0%) | 0% | 0 | Ordinary Shares | |
| uniQure N.V. | Leonard E. Post | Director | Sale of securities on an exchange or to another person at price $ 5.14 per share. | 13 Jun 2024 | 2,222 | 15,999 (0%) | 0% | 5.1 | 11,421 | Ordinary Shares |
| uniQure N.V. | Leonard E. Post | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 17,060 | 17,060 | - | - | Stock Option (Right to Buy) | |
| uniQure N.V. | Leonard E. Post | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 8,700 | 20,512 (0%) | 0% | 0 | Ordinary Shares | |
| uniQure N.V. | Leonard E. Post | Director | Sale of securities on an exchange or to another person at price $ 18.83 per share. | 13 Jun 2023 | 2,291 | 18,221 (0%) | 0% | 18.8 | 43,140 | Ordinary Shares |
| uniQure N.V. | Leonard E. Post | Director | Sale of securities on an exchange or to another person at price $ 19.73 per share. | 27 Feb 2023 | 389 | 11,812 (0%) | 0% | 19.7 | 7,675 | Ordinary Shares |
| Fulgent Genetics Inc | Leonard E. Post | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 8,000 | 8,000 (0%) | 0% | 0 | Common Stock | |
| uniQure N.V. | Leonard E. Post | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 17,810 | 17,810 | - | - | Stock Option (Right to Buy) | |
| uniQure N.V. | Leonard E. Post | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 9,080 | 12,201 (0%) | 0% | 0 | Ordinary Shares | |
| uniQure N.V. | Leonard E. Post | Director | Sale of securities on an exchange or to another person at price $ 16.64 per share. | 28 Feb 2022 | 795 | 3,121 (0%) | 0% | 16.6 | 13,229 | Ordinary Shares |
| uniQure N.V. | Leonard E. Post | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 2,645 | 2,645 | - | - | Stock Option (Right to Buy) | |
| uniQure N.V. | Leonard E. Post | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 1,534 | 3,916 (0%) | 0% | 0 | Ordinary Shares | |
| uniQure N.V. | Leonard E. Post | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 4,107 | 4,107 | - | - | Stock Option (Right to Buy) | |
| uniQure N.V. | Leonard E. Post | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 2,382 | 2,382 (0%) | 0% | 0 | Ordinary Shares | |
| uniQure N.V. | Leonard E. Post | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 10,000 | 10,000 | - | - | Stock option (Right to Buy) |